Search results
Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy By Reuters
Investing.com· 2 days agoA U.S. Senate health panel vote that was scheduled for its June 18 meeting, to decide whether to...
US Senate panel to weigh Novo Nordisk subpoena over Ozempic, Wegovy prices By Reuters
Investing.com· 5 days agoWASHINGTON (Reuters) -The U.S. Senate health panel said on Tuesday it would vote this month on...
Bernie Sanders Aims To Subpoena Novo Nordisk Over Prices
MediaPost· 4 days agoThe U.S. prices of Wegovy and Ozempic are far higher than the prices paid in other countries, Sanders alleges.
Added health benefits of Wegovy, Zepbound could attract more men, doctors say
Reuters via Yahoo News· 7 days agoEvidence that weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound can cut heart...
Second Chinese drugmaker seeks approval for Ozempic generic
WSAU Wausau· 3 days agoBy Andrew Silver SHANGHAI (Reuters) - A second Chinese drugmaker has applied for approval to sell a...
Merck pursuing next-generation opportunities in cardiometabolic drugs
Reuters via Yahoo News· 5 days ago(Reuters) -Merck is focused on second- and third-generation opportunities in the cardiometabolic...
Eli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
Yahoo Finance via AOL· 6 days agoEli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound —...
Dsm-firmenich sees boost as weight-loss drugs spur healthier choices
Reuters via AOL· 6 days ago(Reuters) -The soaring popularity of weight-loss drugs are likely to spur demand for dietary supplements and healthier food formulations, creating growth opportunities for ...
StreetInsider.com - Reuters
StreetInsider· 1 day agoItaly's Meloni shows her arch-conservative credentials at G7 summit Jun 15, 2024 11:15AM By Crispian Balmer BARI, Italy (Reuters) - Since taking office in 2022, Italian Prime ...
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters· 3 days agoAbout one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes...